PepGen (PEPG) Total Liabilities (2021 - 2026)
PepGen (PEPG) posted Total Liabilities of $22.3 million for Q1 2026, down 15.67% sequentially from $26.5 million in Q4 2025, and down 37.3% YoY from $35.6 million in Q1 2025.
Analysis
PepGen (PEPG) Total Liabilities (2021 - 2026) Analysis & Trends
PepGen has reported Total Liabilities for 6 years, with the latest figure at $22.3 million in Q1 2026.
- Quarterly Total Liabilities fell 37.3% year-over-year to $22.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.3 million (down 37.3% YoY) and the FY2025 annual result came in at $26.5 million, down 17.98% from the prior year.
- Total Liabilities fell to $22.3 million in Q1 2026 per PEPG's latest filing, from $26.5 million in the prior quarter.
- Over five years, Total Liabilities peaked at $38.5 million in Q2 2024 and troughed at $15.5 million in Q3 2022.
- A 5-year average of $29.9 million and a median of $32.3 million in 2024 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2026: Total Liabilities soared 258.48% in 2022, then tumbled 37.3% in 2026.
- Over 5 years, Total Liabilities stood at $37.8 million in 2022, then decreased by 8.41% to $34.6 million in 2023, then retreated by 6.84% to $32.3 million in 2024, then declined by 17.98% to $26.5 million in 2025, then declined by 15.67% to $22.3 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $22.3 million, $26.5 million, and $26.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 4.20 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 1.72 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 4.00 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 10.03 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.35 Bn |
| 10 | PepGen | 217.99 Mn | 217.99 Mn | - | 21.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.86 Mn |
| Mar 31, 2026 | 22.32 Mn |
| Dec 31, 2025 | 26.46 Mn |
| Sep 30, 2025 | 26.92 Mn |
| Jun 30, 2025 | 31.08 Mn |
| Mar 31, 2025 | 35.59 Mn |
| Dec 31, 2024 | 32.26 Mn |
| Sep 30, 2024 | 32.78 Mn |
| Jun 30, 2024 | 38.47 Mn |
| Mar 31, 2024 | 28.00 Mn |
| Dec 31, 2023 | 34.63 Mn |
| Sep 30, 2023 | 38.41 Mn |
| Jun 30, 2023 | 34.80 Mn |
| Mar 31, 2023 | 36.20 Mn |
| Dec 31, 2022 | 37.81 Mn |
| Sep 30, 2022 | 15.52 Mn |
| Jun 30, 2022 | 20.58 Mn |
| Mar 31, 2022 | 16.29 Mn |
| Dec 31, 2021 | 10.55 Mn |
| Sep 30, 2021 | 25.61 Mn |